APA (7th ed.) Citation

Teich, K., Krzykalla, J., Kapp-Schwoerer, S., Gaidzik, V. I., Schlenk, R. F., Paschka, P., . . . Thol, F. (2021). Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin. Haematologica, 106(11), . https://doi.org/10.3324/haematol.2021.278894

Chicago Style (17th ed.) Citation

Teich, Katrin, et al. "Cluster of Differentiation 33 Single Nucleotide Polymorphism Rs12459419 Is a Predictive Factor in Patients with Nucleophosmin1-mutated Acute Myeloid Leukemia Receiving Gemtuzumab Ozogamicin." Haematologica 106, no. 11 (2021). https://doi.org/10.3324/haematol.2021.278894.

MLA (9th ed.) Citation

Teich, Katrin, et al. "Cluster of Differentiation 33 Single Nucleotide Polymorphism Rs12459419 Is a Predictive Factor in Patients with Nucleophosmin1-mutated Acute Myeloid Leukemia Receiving Gemtuzumab Ozogamicin." Haematologica, vol. 106, no. 11, 2021, https://doi.org/10.3324/haematol.2021.278894.